Deep Learning Pathomics for Predicting Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, with a five-year survival rate around 10%. Traditional prognostic methods, including imaging and blood markers like CA19-9, often fail to accurately predict therapeutic responses and outcomes. This research aims to enhance the prediction of disea...